Economic Burden of ICU Diseases and Injuries in Brazil During the COVID-19 Pandemic

Author(s)

Bezerra I, Tavares Malheiro D, Nassar Junior AP, Pereira AJ
Hospital Israelita Albert Einstein, São Paulo, SP, Brazil

OBJECTIVES: Direct medical costs incurred during ICU hospitalization are particularly relevant due to their high cost to health system. This study aimed to evaluate the economic burden of diseases and injuries incurred during ICU admissions in a low-income country (Brazil), during the pandemic.

METHODS: Epidemiological data and patient-level costs were collected from 10 ICUs from all Brazilian regions, between January/2020 to December/2021. Data was extracted from the Impacto-MR, a collaborative research platform coordinated by six Brazilian hospitals, including Hospital Israelita Albert Einstein, in partnership with the Ministry of Health and the National Health Surveillance Agency(ANVISA). A standardized absorption methodology was developed from the hospital perspective to measure ICU admissions’ costs. Measured cost components included ICU staff, depreciation, electricity, water, telephone, internet, medical gases, overheads, drugs, office and medical supplies, hemodialysis, blood transfusions, and lab/imaging tests. Clinical conditions were classified following the Global Burden of Diseases standards.

RESULTS: Non-communicable diseases (i.e. cardiovascular, and chronic respiratory diseases, cancer, etc.) were the main cause with 58.4% of total economic burden of US$ 81 million, followed by communicable, maternal, neonatal, and nutritional diseases, with 28.2%. Considering level2, Respiratory infections and tuberculosis incurred the highest costs for both men and women, accounting for 22.0% of total economic burden and a median cost of US$7,146/patient, mostly associated with COVID-19. Cardiovascular (16.9%) and digestive diseases (12.1%) incurred as the next higher costs. For all diseases and injuries, the cost of ICU staff was the highest, followed by overhead and drugs.

CONCLUSIONS: More than half of the economic burden of ICUs is associated with non-communicable diseases. However, respiratory infections and tuberculosis were the cause that absorbed the most resources in 2020 and 2021. The economic burden of diseases and injuries is dynamic and regular monitoring can help prioritize interventions and improve the allocation of limited resources.

Conference/Value in Health Info

2024-05, ISPOR 2024, Atlanta, GA, USA

Value in Health, Volume 27, Issue 6, S1 (June 2024)

Code

EE354

Topic

Economic Evaluation, Study Approaches

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis, Prospective Observational Studies

Disease

Cardiovascular Disorders (including MI, Stroke, Circulatory), Gastrointestinal Disorders, Infectious Disease (non-vaccine), Injury & Trauma, No Additional Disease & Conditions/Specialized Treatment Areas

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×